Healthcare
M&A Advisory
Manufacturing
Pharmaceutical
Marketing
Research
M&A Advisory
Lazard
Full Credential Description
Shionogi & Co., Ltd.. Japan. Announced Date 02/08/2016. Closed Date 01/12/2016. Deal value: $151m. Transfer of Marketing and Manufacturing Rights for Twenty-one of Shionogi's Long-listed Drugs to Lupin's Subsidiary Kyowa Pharmaceutical in Japan. Industry: Shionogi & Co., Ltd. is a pharmaceutical company specializing in research, development, and marketing of medicines.